127 related articles for article (PubMed ID: 30580725)
1. Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk.
Viscoli CM; Kent DM; Conwit R; Dearborn JL; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Stuart A; Young LH; Kernan WN;
Stroke; 2019 Jan; 50(1):95-100. PubMed ID: 30580725
[TBL] [Abstract][Full Text] [Related]
2. Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
Kernan WN; Viscoli CM; Dearborn JL; Kent DM; Conwit R; Fayad P; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Stuart A; Young LH;
JAMA Neurol; 2017 Nov; 74(11):1319-1327. PubMed ID: 28975241
[TBL] [Abstract][Full Text] [Related]
3. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
Viscoli CM; Inzucchi SE; Young LH; Insogna KL; Conwit R; Furie KL; Gorman M; Kelly MA; Lovejoy AM; Kernan WN;
J Clin Endocrinol Metab; 2017 Mar; 102(3):914-922. PubMed ID: 27935736
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
Spence JD; Viscoli C; Kernan WN; Young LH; Furie K; DeFronzo R; Abdul-Ghani M; Dandona P; Inzucchi SE
Diabetes Obes Metab; 2022 Jun; 24(6):1150-1158. PubMed ID: 35253334
[TBL] [Abstract][Full Text] [Related]
9. Adherence to study drug in a stroke prevention trial"?>.
Kiran A; Viscoli CM; Furie KL; Gorman M; Kernan WN
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105048. PubMed ID: 32912514
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
Viscoli CM; Brass LM; Carolei A; Conwit R; Ford GA; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Lovejoy AM; Parsons MW; Peduzzi PN; Ringleb PA; Schwartz GG; Spence JD; Tanne D; Young LH; Kernan WN;
Am Heart J; 2014 Dec; 168(6):823-9.e6. PubMed ID: 25458644
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
Diabetes Care; 2016 Oct; 39(10):1684-92. PubMed ID: 27465265
[TBL] [Abstract][Full Text] [Related]
12. Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights.
Vallarino C; Perez A; Fusco G; Liang H; Bron M; Manne S; Joseph G; Yu S
Clin Drug Investig; 2013 Sep; 33(9):621-31. PubMed ID: 23881565
[TBL] [Abstract][Full Text] [Related]
13. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
14. Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.
Furie KL; Viscoli CM; Gorman M; Ford GA; Young LH; Inzucchi SE; Guarino PD; Lovejoy AM; Conwit R; Tanne D; Kernan WN;
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):21-27. PubMed ID: 28939682
[TBL] [Abstract][Full Text] [Related]
15. Effect of pioglitazone on vascular events in post-stroke cognitive impairment: Post hoc analysis of the IRIS trial.
Schmidt K; Power MC; Ciarleglio A; Nadareishvili Z
Int J Stroke; 2024 Apr; 19(4):414-421. PubMed ID: 38148372
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
[TBL] [Abstract][Full Text] [Related]
18. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670
[TBL] [Abstract][Full Text] [Related]
20. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04).
Wilcox R; Bousser MG; Betteridge DJ; Schernthaner G; Pirags V; Kupfer S; Dormandy J;
Stroke; 2007 Mar; 38(3):865-73. PubMed ID: 17290029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
